Merck Animal Health received U.S. Food and Drug Administration approval for an extended-duration topical solution that protects cats from fleas, ticks, and other parasites. Called Bravecto Plus, the drug is comprised of fluralaner and moxidectin, and can be used to treat both external and internal infestations. The formula offers cats protection for two months.
